Results 201 to 210 of about 190,239 (217)

Vaccine therapy for malignant melanoma†

Ca-A Cancer Journal for Clinicians, 1996
D L Morton
exaly  

The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety

Vaccine, 2014
Allison L. Naleway, Edward A Belongia, Grace Lee   +2 more
exaly  

Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink

Vaccine, 2011
Allison L. Naleway, Martin Kulldorff, Eric Weintraub   +2 more
exaly  

Current controversies in the USA regarding vaccine safety

Expert Review of Vaccines, 2010
Archana Chatterjee
exaly  

Safety and immunogenicity of a 9-valent HPV vaccine in females 12–26 years of age who previously received the quadrivalent HPV vaccine

Vaccine, 2015
Josefina Romaguera, Lone Kjeld Petersen, Suzanne Marie Garland   +2 more
exaly  

Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04

Vaccine, 2004
Jane N Zuckerman, J van Hattum, B Genton
exaly  

Guide to active vaccine safety surveillance: Report of CIOMS working group on vaccine safety – executive summary

Vaccine, 2017
Harry A Seifert, Ulrich Heininger, Priya Bahri   +2 more
exaly  

Human therapeutic cocaine vaccine: safety and immunogenicity

Vaccine, 2002
Thomas R Kosten, Marc I Rosen
exaly  

Effective vaccine safety systems in all countries: A challenge for more equitable access to immunization

Vaccine, 2013
Heidi J. Larson, Philipp Lambach, Ananda Amarasinghe   +2 more
exaly  

An assessment of the safety of adolescent and adult tetanus–diphtheria–acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink

Vaccine, 2009
Katherine Yih
exaly